HUMACYTE INC
HUMA·44486Q103·US·Common Stock·Healthcare - Biotechnology-Activist
HUMA (HUMACYTE INC) is held by 80 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($7.9M), Alyeska Investment Group, L.P. ($4.7M), BlackRock, Inc. ($3.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 46 funds bought HUMA.
80
Holders
(7 Elite)
$35.9M
Total Value
50% (92)
Consensus
46 buying - 46 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 18, 2026 · Insiders Aug 20, 2025 · Activists Jul 28, 2026 · Congress Aug 5, 2026
ActivistDKDavidson Kempner Capital Management LP4.7%Jun 22, 2026
InsiderDWDougan Brady WSell $935KAug 20, 2025
Checking access…
Top Holders
Checking access…
Showing 1-20 of 99
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $667.3B
413 holders · $186.4B
394 holders · $391.5B
392 holders · $97.1B
391 holders · $127.1B
391 holders · $147.4B
389 holders · $77B
385 holders · $209.1B
381 holders · $255.1B
380 holders · $129.4B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer